Emergent BioSolutions
EBS
#8517
Rank
NZ$0.47 B
Marketcap
NZ$9.30
Share price
-1.07%
Change (1 day)
-47.21%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -NZ$0.35 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.62 Billion. In 2025 the company made an earning of NZ$0.25 Billion, an increase over its 2024 earnings that were of -NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.35 Billion-232.09%
2025 NZ$0.25 B-297.64%
2024 -NZ$0.14 Billion-88.82%
2023 -NZ$1.18 Billion242.73%
2022 -NZ$0.35 Billion-153.8%
2021 NZ$0.63 B-20.43%
2020 NZ$0.80 B278.02%
2019 NZ$0.21 B27.11%
2018 NZ$0.16 B-27.12%
2017 NZ$0.22 B17.21%
2016 NZ$0.19 B0.45%
2015 NZ$0.19 B73.51%
2014 NZ$0.11 B41.36%
2013 NZ$79.14 M35.2%
2012 NZ$58.54 M0.4%
2011 NZ$58.31 M-56.46%
2010 NZ$0.13 B76.73%
2009 NZ$75.77 M32.94%
2008 NZ$56.99 M-5.62%
2007 NZ$60.39 M
2005 NZ$87.44 M269.89%
2004 NZ$23.64 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.71 B-3,680.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.27 B-3,554.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.05 B-3,776.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$21.37 Million-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-NZ$20.33 Million-94.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion 67.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.23 B-728.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel